An Open-Label, Single Arm, Clinical Study to Evaluate the Safety of HORS-051511 in Healthy Adults - NII

Himalaya Wellness Company (HWC)0 个研究点目标入组 12 人开始时间: 待定最近更新: 2024年7月22日

试验速览

暂无简介。

•1.Healthy adult subjects, both men and women within age group of 18 to 45 years.
•2.Subjects willing to sign an informed consent document.
•3.Subjects willing to adhere to protocol requirements throughout the study period.
•4.Subjects who have not participated in any clinical study in the past 30 days.
•5.Subjects who are willing to do moderate and vigorous physical activities at least 4 times a week as reported by the subjects. (Appendix I)

•1.Women who are pregnant, nursing, or planning a pregnancy during study entry and through the duration of the study.
•2.Subjects with known allergies to any of the ingredients of the test product.
•3.Subject with clinically significant abnormal lab values detected at the time of screening as determined by the investigator.
•4.Subject who had a history of hypersensitivity to any packaged rehydration beverage.
•5.Subjects with clinically significant serious cardiovascular, cerebrovascular, respiratory, liver, renal disease, congenital or any other disorder as determined by the investigator.
•6.Subjects with clinically significant pre-existing systemic disease necessitating long-term medications as determined by the investigator.
•7.Subjects not willing to refrain from taking any other similar supplements during the study period.
•8.Subjects not willing to abstain from excessive intake of recreational products like tobacco/pan chewing, smoking, alcohol and any other as determined by the investigator during the study period.

发起方

Himalaya Wellness Company (HWC)